Iovance Biotherapeutics, Inc. is a clinical-stage biopharmaceutical company. The Company develops and delivers tumor infiltrating lymphocyte (TIL), therapies for patients with solid tumor cancers. Its lead product candidate, Amtagvi (lifileucel), is a tumor-derived autologous T cell immunotherapy indicated for the treatment of adult patients with unresectable or metastatic melanoma previously treated with a PD-1 blocking antibody, and if BRAF V600 mutation positive, a BRAF inhibitor with or without a MEK inhibitor. The Company also marketing Proleukin (aldesleukin), aninterleukin-2, or IL-2, product used in the Amtagvi treatment regimen. Its development pipeline includes multicenter trials of TIL cell therapies in additional treatment settings for solid tumor cancers. Amtagvi and Proleukin are part of a treatment regimen that also includes lymphodepletion. The Company is also developing next generation therapies using TIL, such as genetically modified TIL cell therapy.
What is the share price of Iovance Biotherapeutics, Inc. today?
Iovance Biotherapeutics, Inc. (IOVA) share price as of March 27, 2026 is $3.69. If you are investing from India, you can always check the valuation in the INR before investing.
Can Indian Investors purchase shares of Iovance Biotherapeutics, Inc.?
Yes, Indian Investors can invest in the Iovance Biotherapeutics, Inc. (IOVA) Share by opening an international trading account with Angel One.
How can I purchase Iovance Biotherapeutics, Inc. shares in India?
Purchasing Iovance Biotherapeutics, Inc. (IOVA) share from India can be done by: Directly: By opening an international trading account with Angel One. The process would include KYC verification. The account activation takes a few minutes to a few hours, after which you can start buying Iovance Biotherapeutics, Inc. (IOVA) by making deposits in US dollars. Indirectly: By investing in mutual funds and Exchange Traded Funds (ETF) that offers exposure in global stocks.
Can I buy Fractional shares of Iovance Biotherapeutics, Inc.?
Yes, you can purchase fractional shares of Iovance Biotherapeutics, Inc. (IOVA) or any other US company shares in Angel One for any dollar amount.
What is the market capitalization value of Iovance Biotherapeutics, Inc.?
The market capitalization of Iovance Biotherapeutics, Inc. on February 11, 2026, is $1.52 B.
In which sector Iovance Biotherapeutics, Inc. belongs?
Iovance Biotherapeutics, Inc. operates in the Healthcare sector, specifically in the Biotechnology industry.
What documents are required to invest in Iovance Biotherapeutics, Inc. stocks?
In order to invest in Iovance Biotherapeutics, Inc. (IOVA) you will need Proof of Identification (Aadhaar, PAN, Passport etc.) and Proof of Address (Aadhaar, Voter Card etc.). From start to end, the process is digital and can be seamless.
